1-5 April 2017 More Info
Built over twenty years on the world's largest collection of human genomes, our platform today powers the biggest and most innovative precision medicine efforts on four continents, including pioneering population-optimized genome tests and wellness products in China.Our Story
Read about us on the front page of the Washington Post
More genomes run on WuXi NextCODE than on any other platform in the world. That's because only we can put all your genomic data at your fingertips, wherever it resides, enabling you to identify variations in the sequence of the genome linked with virtually any phenotype, at scale, in real time, at raw resolution, online.
The only database built for genomes
Integrated, scalable analytics and deep learning to link genome variation to phenotype
Use massive sequence data in full resolution online
The first focus of our product portfolio is to deliver population-optimized diagnostics, carrier screening and whole-genome wellness scans in China.
Pediatric rare disease diagnostics
Whole-genome consumer wellness scan
Pioneering pre-conception carrier screening
Our infrastructure underpins the world's most advanced population projects; rare disease and cancer diagnostics at the preeminent pediatric hospitals and programs in the US, China and Europe; the application of genome-phenotype links to a range of health challenges; and pioneering scientific wellness.
Teaming up with AbbVie and GMI in one of the largest preclinical genomics partnerships to date Read MoreOur News